BENJAMIN F. EDWARDS & COMPANY, INC. - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
BENJAMIN F. EDWARDS & COMPANY, INC. ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$9
-18.2%
1,1300.0%0.00%
Q2 2023$11
-8.3%
1,1300.0%0.00%
-100.0%
Q1 2023$12
+140.0%
1,1300.0%0.00%
Q4 2022$5
-100.0%
1,130
-93.0%
0.00%
-100.0%
Q3 2022$121,000
+8.0%
16,130
+44.9%
0.01%
+20.0%
Q2 2022$112,000
-18.8%
11,1300.0%0.01%
-16.7%
Q1 2022$138,000
-45.9%
11,1300.0%0.01%
-45.5%
Q4 2021$255,000
+3.7%
11,1300.0%0.01%
-8.3%
Q3 2021$246,000
+70.8%
11,1300.0%0.01%
+71.4%
Q2 2021$144,000
+21.0%
11,130
+21.9%
0.01%
+16.7%
Q1 2021$119,000
-22.7%
9,130
-18.0%
0.01%
-33.3%
Q4 2020$154,000
+4.8%
11,130
+11.3%
0.01%
-10.0%
Q3 2020$147,000
-9.8%
10,0000.0%0.01%
-16.7%
Q2 2020$163,000
+12.4%
10,0000.0%0.01%0.0%
Q1 2020$145,000
-28.6%
10,0000.0%0.01%
-14.3%
Q4 2019$203,000
+283.0%
10,0000.0%0.01%
+250.0%
Q3 2019$53,000
+15.2%
10,000
+42.9%
0.00%0.0%
Q2 2019$46,000
+253.8%
7,000
+250.0%
0.00%
+300.0%
Q1 2019$13,000
-7.1%
2,0000.0%0.00%0.0%
Q4 2018$14,000
+7.7%
2,0000.0%0.00%0.0%
Q3 2018$13,000
+18.2%
2,0000.0%0.00%0.0%
Q2 2018$11,0002,0000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders